NCT05923502 2023-10-23(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)Ruijin HospitalNot yet recruiting200 enrolled
NCT02576275 2021-03-17A Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA)SecuraBioPhase 3 Withdrawn